If you look at the summary at the end of the 4kids
Post# of 72440
(Total Views: 1671)
Posted On: 10/17/2020 11:28:14 PM
If you look at the summary at the end of the 4kids post #66879 some of the numbers and events jump off the page.
2015 – IPIX SP begins year at $3.66 after peaking at $4.93 in December 2014
8/6/15 Mako hit piece immediately followed by bogus Rosen Class Action
2016 – IPIX SP begins year at $1.28
2017 – IPIX SP begins the year at $1.16 and closes year end at .73
2018 - 88M shares traded
-A then record amount of 55M or about 63% of the entire year total was traded in the last 4 months which was needed to compress IPIX SP from .53 to .07
2019 – 124M (almost a 50% increase in volume from 2018)
- May 2019 alone was 23M to negate the Alfasigma announcement
- YTD through October was 94M and 30M in the last 3 months to compress further down to .05 SP. NR had successfully crippled IPIX down to 5 cents a share making capital extremely expensive and dilutive for any science advancement.
2020 – A successful Phase 1 on B-IBD UC using BDD delivery system gives hope of a future licensing deal into a huge IBD market but then…….A worldwide pandemic strikes that no one saw coming INCLUDING the criminal cabal (also referred to as Non Retail or NR). An even bigger surprise is that our little baby bio investment IPIX’s Brilacidin, turns out to have far superior antiviral capabilities versus ANY other drug known to mankind against the CV19 virus and it not only reduces the overall viral load but kills the CV19 virus on contact, reduces inflammation and modulates the human immune response. Now back to the numbers!
2020 first 9 month volume is 524M. Note at this rate IPIX volume will be 699M in 2020 or ALMOST 6 TIMES THE VOLUME OF 2019. I personally believe that the last 10 weeks of volume in 2020 will be far greater than this rate due to milestone achievements discussed below.
Note that September of 2019 IPIX shareholders voted 90% in FAVOR of approving an increase in Authorized Shares from 300M to 600M. IMO this was an extremely strong vote of confidence that a vast majority of IPIX shareholders were in for the LONG haul. This shareholder confidence in IPIX science and management made it clear that very few IPIX investors were selling any of their position at these artificially compressed prices and by knowing what the own would not be selling under a several dollar SP. The criminals/NR know this very well and thus the comment that they are between a rock and a hard place.
A couple of examples of criminally compressed stocks that saw a sudden increase as NR lost control of SP and their naked position was forced into a squeeze.
- AMRN SP went from $3 to $26 in a very short period of time.
- OSTK SP was $2.23 this March and hit a peak of $123.00 this August. Does anyone on this board believe OSTK improved their business model by a factor of 55X over a brief few month period?
The entire contents above are simply proof points of criminal manipulation by NR but IMO IPIX will ultimately be valued based on their science making it through FDA trials and ultimately distributed successfully to the market to treat disease. My track record on predicting timing of events has not been great as I continue to be surprised at how long it takes to advance the science through FDA trials but with that said I believe we are getting very close to hitting some very huge milestones that will continue to de-risk our investment and bring life-saving drugs to the market. I am expecting to see:
In 30 days or less – FDA IND Approval and separately a Preprint of the RBL Peer Review paper.
In 45 days or less – Initiation of B-CV19 Human Trials
In 60-90 days – Interim Human Trial Results, Emergency Use and Compassionate Use approval. Major industry and investor exposure. Multiple media exposure in print, social media, television, radio discussing the treatment that kills CV19.
1stH 2021 – Large government order and/or government grant for volume shipment of Brilacidin for the masses in parallel with a Phase3 B-CV19 trial. International distribution partnership for B-CV19 to cover non-US demand. Separately a B-IBD UC Phase 2 trial kicks off as Brilacidin is further positioned as a franchise drug used for many different instances.
2ndH 2021 – IPIX will most likely have been already Up Listed off of the criminally controlled OTX to a legitimate exchange. Throughout 2021 the criminals will be scrambling to cover their naked position as an EPIC SHORT SQUEEZE takes place starting in the $2-4/share range but really kicking in the $5-$20 range. Remember that the criminals need REAL LONGS to sell REAL SHARES for them to cover their naked positions. IMO it will not be uncommon to see trading days where IPIX is trading at 10M+ shares daily and go up in $1 plus increments on days where no announcements are made. See the above OSTK example for both the magnitude of the SP increase and the short period of time that this could take place.
2015 – IPIX SP begins year at $3.66 after peaking at $4.93 in December 2014
8/6/15 Mako hit piece immediately followed by bogus Rosen Class Action
2016 – IPIX SP begins year at $1.28
2017 – IPIX SP begins the year at $1.16 and closes year end at .73
2018 - 88M shares traded
-A then record amount of 55M or about 63% of the entire year total was traded in the last 4 months which was needed to compress IPIX SP from .53 to .07
2019 – 124M (almost a 50% increase in volume from 2018)
- May 2019 alone was 23M to negate the Alfasigma announcement
- YTD through October was 94M and 30M in the last 3 months to compress further down to .05 SP. NR had successfully crippled IPIX down to 5 cents a share making capital extremely expensive and dilutive for any science advancement.
2020 – A successful Phase 1 on B-IBD UC using BDD delivery system gives hope of a future licensing deal into a huge IBD market but then…….A worldwide pandemic strikes that no one saw coming INCLUDING the criminal cabal (also referred to as Non Retail or NR). An even bigger surprise is that our little baby bio investment IPIX’s Brilacidin, turns out to have far superior antiviral capabilities versus ANY other drug known to mankind against the CV19 virus and it not only reduces the overall viral load but kills the CV19 virus on contact, reduces inflammation and modulates the human immune response. Now back to the numbers!
2020 first 9 month volume is 524M. Note at this rate IPIX volume will be 699M in 2020 or ALMOST 6 TIMES THE VOLUME OF 2019. I personally believe that the last 10 weeks of volume in 2020 will be far greater than this rate due to milestone achievements discussed below.
Note that September of 2019 IPIX shareholders voted 90% in FAVOR of approving an increase in Authorized Shares from 300M to 600M. IMO this was an extremely strong vote of confidence that a vast majority of IPIX shareholders were in for the LONG haul. This shareholder confidence in IPIX science and management made it clear that very few IPIX investors were selling any of their position at these artificially compressed prices and by knowing what the own would not be selling under a several dollar SP. The criminals/NR know this very well and thus the comment that they are between a rock and a hard place.
A couple of examples of criminally compressed stocks that saw a sudden increase as NR lost control of SP and their naked position was forced into a squeeze.
- AMRN SP went from $3 to $26 in a very short period of time.
- OSTK SP was $2.23 this March and hit a peak of $123.00 this August. Does anyone on this board believe OSTK improved their business model by a factor of 55X over a brief few month period?
The entire contents above are simply proof points of criminal manipulation by NR but IMO IPIX will ultimately be valued based on their science making it through FDA trials and ultimately distributed successfully to the market to treat disease. My track record on predicting timing of events has not been great as I continue to be surprised at how long it takes to advance the science through FDA trials but with that said I believe we are getting very close to hitting some very huge milestones that will continue to de-risk our investment and bring life-saving drugs to the market. I am expecting to see:
In 30 days or less – FDA IND Approval and separately a Preprint of the RBL Peer Review paper.
In 45 days or less – Initiation of B-CV19 Human Trials
In 60-90 days – Interim Human Trial Results, Emergency Use and Compassionate Use approval. Major industry and investor exposure. Multiple media exposure in print, social media, television, radio discussing the treatment that kills CV19.
1stH 2021 – Large government order and/or government grant for volume shipment of Brilacidin for the masses in parallel with a Phase3 B-CV19 trial. International distribution partnership for B-CV19 to cover non-US demand. Separately a B-IBD UC Phase 2 trial kicks off as Brilacidin is further positioned as a franchise drug used for many different instances.
2ndH 2021 – IPIX will most likely have been already Up Listed off of the criminally controlled OTX to a legitimate exchange. Throughout 2021 the criminals will be scrambling to cover their naked position as an EPIC SHORT SQUEEZE takes place starting in the $2-4/share range but really kicking in the $5-$20 range. Remember that the criminals need REAL LONGS to sell REAL SHARES for them to cover their naked positions. IMO it will not be uncommon to see trading days where IPIX is trading at 10M+ shares daily and go up in $1 plus increments on days where no announcements are made. See the above OSTK example for both the magnitude of the SP increase and the short period of time that this could take place.
(28)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼